290 related articles for article (PubMed ID: 22171257)
41. The biology of beta human papillomaviruses.
Tommasino M
Virus Res; 2017 Mar; 231():128-138. PubMed ID: 27856220
[TBL] [Abstract][Full Text] [Related]
42. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6.
McKenna DJ; McDade SS; Patel D; McCance DJ
J Virol; 2010 Oct; 84(20):10644-52. PubMed ID: 20702634
[TBL] [Abstract][Full Text] [Related]
44. Oncogenic potential diverge among human papillomavirus type 16 natural variants.
Sichero L; Sobrinho JS; Villa LL
Virology; 2012 Oct; 432(1):127-32. PubMed ID: 22748253
[TBL] [Abstract][Full Text] [Related]
45. Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles.
Harden ME; Munger K
Virology; 2017 Aug; 508():63-69. PubMed ID: 28500882
[TBL] [Abstract][Full Text] [Related]
46. The E7 protein of the cottontail rabbit papillomavirus immortalizes normal rabbit keratinocytes and reduces pRb levels, while E6 cooperates in immortalization but neither degrades p53 nor binds E6AP.
Ganzenmueller T; Matthaei M; Muench P; Scheible M; Iftner A; Hiller T; Leiprecht N; Probst S; Stubenrauch F; Iftner T
Virology; 2008 Mar; 372(2):313-24. PubMed ID: 18067942
[TBL] [Abstract][Full Text] [Related]
47. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
48. Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance.
Murakami I; Egawa N; Griffin H; Yin W; Kranjec C; Nakahara T; Kiyono T; Doorbar J
PLoS Pathog; 2019 May; 15(5):e1007755. PubMed ID: 31083694
[TBL] [Abstract][Full Text] [Related]
49. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
[TBL] [Abstract][Full Text] [Related]
50. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.
Ganguly N; Parihar SP
J Biosci; 2009 Mar; 34(1):113-23. PubMed ID: 19430123
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus type 16 E6 induces cell competition.
Brimer N; Vande Pol S
PLoS Pathog; 2022 Mar; 18(3):e1010431. PubMed ID: 35320322
[TBL] [Abstract][Full Text] [Related]
53. Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins.
Castagnino P; Kim HW; Lam LKM; Basu D; White EA
J Virol; 2022 Nov; 96(22):e0132622. PubMed ID: 36342298
[TBL] [Abstract][Full Text] [Related]
54. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
[TBL] [Abstract][Full Text] [Related]
55. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown.
Diaz D; Santander MA; Chavez JA
Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553
[TBL] [Abstract][Full Text] [Related]
56. Activation of telomerase by HPVs.
Katzenellenbogen RA
Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966
[TBL] [Abstract][Full Text] [Related]
57. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs.
Uversky VN; Roman A; Oldfield CJ; Dunker AK
J Proteome Res; 2006 Aug; 5(8):1829-42. PubMed ID: 16889404
[TBL] [Abstract][Full Text] [Related]
58. Transforming properties of Felis catus papillomavirus type 2 E6 and E7 putative oncogenes in vitro and their transcriptional activity in feline squamous cell carcinoma in vivo.
Altamura G; Corteggio A; Pacini L; Conte A; Pierantoni GM; Tommasino M; Accardi R; Borzacchiello G
Virology; 2016 Sep; 496():1-8. PubMed ID: 27236740
[TBL] [Abstract][Full Text] [Related]
59. The biological properties of E6 and E7 oncoproteins from human papillomaviruses.
Ghittoni R; Accardi R; Hasan U; Gheit T; Sylla B; Tommasino M
Virus Genes; 2010 Feb; 40(1):1-13. PubMed ID: 19838783
[TBL] [Abstract][Full Text] [Related]
60. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
